Relapsing/refractory HL after autotransplantation: which treatment?

For advanced-stage Hodgkin lymphoma (HL), front-line chemotherapy, alone or in combination with radiotherapy, leads to 5-year progression-free survival (PFS) rates and freedom-from-treatment failure (FFTF) rates of 70-85%, regardless of the chemotherapy regimen applied. Patients with HL experiencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Renzo, Nicola, Gaudio, Francesco, Carlo Stella, Carmelo, Oppi, Sara, Pelosini, Matteo, Sorasio, Roberto, Stelitano, Caterina, Rigacci, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
How I Treat
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944654/
https://www.ncbi.nlm.nih.gov/pubmed/32525132
http://dx.doi.org/10.23750/abm.v91iS-5.9912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944654/
https://www.ncbi.nlm.nih.gov/pubmed/32525132
http://dx.doi.org/10.23750/abm.v91iS-5.9912

Ejemplares similares